Effects of the angiotensin receptor-neprilysin inhibitor/sacubitril-valsartan administration on quality of life and outcome in heart failure with reduced ejection fraction: a meta analysis

被引：0
|
作者：
Dewi, Kadek Intan Murti [1 ]
Pintaningrum, Yusra [1 ]
机构：
[1] Mataram Univ, Dept Cardiovasc Med, Fac Med, Mataram, Indonesia
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2021年 / 23卷 / 0F期
关键词：
HFrEF; sacubitril-valsartan; quality of life;
D O I：
10.1093/eurheartjsupp/suab123.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
M7
引用
收藏
页数：1
相关论文
共 50 条
  • [1] M7. Effects of the angiotensin receptor-neprilysin inhibitor/sacubitril-valsartan administration on quality of life and outcome in heart failure with reduced ejection fraction: a meta analysis
    Dewi, Kadek Intan Murti
    Pintaningrum, Yusra
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL F)
  • [2] Six months clinical and echocardiographic outcome of angiotensin receptor-neprilysin inhibitor (sacubitril/valsartan) therapy in heart failure patients with reduced ejection fraction
    Alnims, M. Mohammed
    Magdy, Abdelhamid
    Meguid, M. Abdel
    Ahmed, Shehata
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 101 - 102
  • [3] Angiotensin receptor-neprilysin inhibitor adherence and outcomes in heart failure with reduced ejection fraction
    Cho, Dong-Hyuk
    Choi, Jimi
    Youn, Jong-Chan
    Kim, Mi-Na
    Lee, Chan Joo
    Son, Jung-Woo
    Yoo, Byung-Su
    ESC HEART FAILURE, 2025, 12 (01): : 603 - 612
  • [4] Outcome of angiotensin receptor-neprilysin inhibitor on anxiety and depression in heart failure with reduced ejection fraction vs. heart failure with preserved ejection fraction
    Malik, Jahanzeb
    Shahid, Abdul Wahab
    Shah, Mohsin
    Rana, Ghazanfar
    Kamal, Ahmed
    Naeem, Hesham
    JOURNAL OF COMMUNITY HOSPITAL INTERNAL MEDICINE PERSPECTIVES, 2021, 11 (05): : 629 - 634
  • [5] Benefits of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure with Reduced Ejection Fraction: A Longitudinal Study
    Jain, Dharmendra
    Pandey, Umesh Kumar
    Tripathi, Suyash
    Kaushley, Abhishek
    Verma, Bhupendra
    Ghosh, Soumik
    Santosh, Krishna Vemuri
    Prajapati, Rajpal
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (04) : EC17 - EC22
  • [6] Effect of angiotensin receptor-neprilysin inhibitor treatment on erectile dysfunction in heart failure with a reduced ejection fraction
    Sert, Sena
    Karabay, Emre
    Gungor, Baris
    Yildirimturk, Ozlem
    MARMARA MEDICAL JOURNAL, 2023, 36 (01): : 99 - 104
  • [7] Clinical efficacy of angiotensin receptor-neprilysin inhibitor in de novo heart failure with reduced ejection fraction
    Park, Su Yeong
    Kong, Min Gyu
    Moon, Inki
    Park, Hyun Woo
    Choi, Hyung-Oh
    Seo, Hye Sun
    Cho, Yoon Haeng
    Lee, Nae-Hee
    Lee, Kwan Yong
    Jang, Ho-Jun
    Kim, Je Sang
    Choi, Ik Jun
    Suh, Jon
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (05): : 692 - 703
  • [8] Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fraction
    Docherty, Kieran F.
    McMurray, John J. V.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 281 : 179 - 185
  • [9] Six months clinical and echocardiographic outcome of angiotensin receptor-neprilysin inhibitor therapy in heart failure patients with reduced ejection fraction
    Alnims, M. Mohammed
    Magdy, Abdelhamid
    Meguid, M. Abdel
    Ahmed, Shehata
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 82 - 83
  • [10] Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction A Paradigm for All?
    Konstam, Marvin A.
    JACC-HEART FAILURE, 2016, 4 (10) : 823 - 825
12345